Piers Morgan appointed as Chief Financial Officer
4D Medicine have recently welcomed Piers Morgan as Chief Financial Officer. Piers has over 20 years of Board level experience in drug discovery and clinical development in biotech, covering both small molecules and gene therapies. In total, Piers has led financings amounting to almost $800m as principal, and a further $700m as an adviser.
CEO Phil Smith said “Piers joins us at a pivotal time in our journey, and his support will be hugely valuable in our next phase of growth. In this new role, Piers will lead the company’s financial strategy and be instrumental in navigating 4D through future funding rounds to support the company’s rapid expansion”.
